Shopping Cart 0
Cart Subtotal
AED 0

Oncomatryx Biopharma SL - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 8258

Details

Summary

Oncomatryx Biopharma SL (Oncomatryx) is a developer of precision drugs. The company offers precision drugs that targets proteins located in the tumor environment. It develops therapeutic antibody-drug conjugates, antibodies, and human-derived proteins, which targets tumor associated stroma. Oncomatryx's products comprise DMTX invaScan, DMTX bladderScan, DMTX breastScan, and companion diagnostics, among others. The company offers sensitive and specific monoclonal antibodies for the diagnosis of invasive carcinomas, among others. It markets its products through a network of distributors in Spain and abroad. Oncomatryx is headquartered in Derio, Spain.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Oncomatryx Biopharma SL

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Oncomatryx Biopharma SL Company Overview 4

Oncomatryx Biopharma SL Company Snapshot 4

Oncomatryx Biopharma SL Pipeline Products and Ongoing Clinical Trials Overview 4

Oncomatryx Biopharma SL-Pipeline Analysis Overview 6

Oncomatryx Biopharma SL-Key Facts 6

Oncomatryx Biopharma SL-Major Products and Services 7

Oncomatryx Biopharma SL Pipeline Products by Development Stage 8

Oncomatryx Biopharma SL Pipeline Products Overview 10

ELISA-Based Companion Diagnostic Kit-MTX3 10

ELISA-Based Companion Diagnostic Kit-MTX3 Product Overview 10

ELISA-Based Companion Diagnostic Kit-MTX5 11

ELISA-Based Companion Diagnostic Kit-MTX5 Product Overview 11

Immunohistochemistry Based Companion Diagnostic Kit-MTX3 12

Immunohistochemistry Based Companion Diagnostic Kit-MTX3 Product Overview 12

Immunohistochemistry Based Companion Diagnostic Kit-MTX5 13

Immunohistochemistry Based Companion Diagnostic Kit-MTX5 Product Overview 13

Oncomatryx Biopharma SL-Key Competitors 14

Oncomatryx Biopharma SL-Key Employees 15

Oncomatryx Biopharma SL-Locations And Subsidiaries 16

Head Office 16

Recent Developments 17

Oncomatryx Biopharma SL, Recent Developments 17

Mar 04, 2013: Oncomatrix Launches New Immunohistochemistry Kit To Diagnose And Prognose Tumor Invasiveness 17

Appendix 18

Methodology 18

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

Oncomatryx Biopharma SL Pipeline Products by Equipment Type 5

Oncomatryx Biopharma SL Pipeline Products by Development Stage 8


List Of Table

List of Tables

Oncomatryx Biopharma SL Pipeline Products and Ongoing Clinical Trials Overview 4

Oncomatryx Biopharma SL Pipeline Products by Equipment Type 5

Oncomatryx Biopharma SL Pipeline Products by Indication 5

Oncomatryx Biopharma SL, Key Facts 6

Oncomatryx Biopharma SL, Major Products and Services 7

Oncomatryx Biopharma SL Number of Pipeline Products by Development Stage 8

Oncomatryx Biopharma SL Pipeline Products Summary by Development Stage 9

ELISA-Based Companion Diagnostic Kit-MTX3-Product Status 10

ELISA-Based Companion Diagnostic Kit-MTX3-Product Description 10

ELISA-Based Companion Diagnostic Kit-MTX5-Product Status 11

ELISA-Based Companion Diagnostic Kit-MTX5-Product Description 11

Immunohistochemistry Based Companion Diagnostic Kit-MTX3-Product Status 12

Immunohistochemistry Based Companion Diagnostic Kit-MTX3-Product Description 12

Immunohistochemistry Based Companion Diagnostic Kit-MTX5-Product Status 13

Immunohistochemistry Based Companion Diagnostic Kit-MTX5-Product Description 13

Oncomatryx Biopharma SL, Key Employees 15

Glossary 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Oncomatryx Biopharma SL, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Spanish Breast Cancer Research Group

Multidisplinary Group on Digestive Cancer

Curaxys SL

Dynamic Solutions

Company Profile

Company Profile Title

Summary

Oncomatryx Biopharma SL (Oncomatryx) is a developer of precision drugs. The company offers precision drugs that targets proteins located in the tumor environment. It develops therapeutic antibody-drug conjugates, antibodies, and human-derived proteins, which targets tumor associated stroma. Oncomatryx's products comprise DMTX invaScan, DMTX bladderScan, DMTX breastScan, and companion diagnostics, among others. The company offers sensitive and specific monoclonal antibodies for the diagnosis of invasive carcinomas, among others. It markets its products through a network of distributors in Spain and abroad. Oncomatryx is headquartered in Derio, Spain.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Oncomatryx Biopharma SL

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Oncomatryx Biopharma SL Company Overview 4

Oncomatryx Biopharma SL Company Snapshot 4

Oncomatryx Biopharma SL Pipeline Products and Ongoing Clinical Trials Overview 4

Oncomatryx Biopharma SL-Pipeline Analysis Overview 6

Oncomatryx Biopharma SL-Key Facts 6

Oncomatryx Biopharma SL-Major Products and Services 7

Oncomatryx Biopharma SL Pipeline Products by Development Stage 8

Oncomatryx Biopharma SL Pipeline Products Overview 10

ELISA-Based Companion Diagnostic Kit-MTX3 10

ELISA-Based Companion Diagnostic Kit-MTX3 Product Overview 10

ELISA-Based Companion Diagnostic Kit-MTX5 11

ELISA-Based Companion Diagnostic Kit-MTX5 Product Overview 11

Immunohistochemistry Based Companion Diagnostic Kit-MTX3 12

Immunohistochemistry Based Companion Diagnostic Kit-MTX3 Product Overview 12

Immunohistochemistry Based Companion Diagnostic Kit-MTX5 13

Immunohistochemistry Based Companion Diagnostic Kit-MTX5 Product Overview 13

Oncomatryx Biopharma SL-Key Competitors 14

Oncomatryx Biopharma SL-Key Employees 15

Oncomatryx Biopharma SL-Locations And Subsidiaries 16

Head Office 16

Recent Developments 17

Oncomatryx Biopharma SL, Recent Developments 17

Mar 04, 2013: Oncomatrix Launches New Immunohistochemistry Kit To Diagnose And Prognose Tumor Invasiveness 17

Appendix 18

Methodology 18

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

Oncomatryx Biopharma SL Pipeline Products by Equipment Type 5

Oncomatryx Biopharma SL Pipeline Products by Development Stage 8


List Of Table

List of Tables

Oncomatryx Biopharma SL Pipeline Products and Ongoing Clinical Trials Overview 4

Oncomatryx Biopharma SL Pipeline Products by Equipment Type 5

Oncomatryx Biopharma SL Pipeline Products by Indication 5

Oncomatryx Biopharma SL, Key Facts 6

Oncomatryx Biopharma SL, Major Products and Services 7

Oncomatryx Biopharma SL Number of Pipeline Products by Development Stage 8

Oncomatryx Biopharma SL Pipeline Products Summary by Development Stage 9

ELISA-Based Companion Diagnostic Kit-MTX3-Product Status 10

ELISA-Based Companion Diagnostic Kit-MTX3-Product Description 10

ELISA-Based Companion Diagnostic Kit-MTX5-Product Status 11

ELISA-Based Companion Diagnostic Kit-MTX5-Product Description 11

Immunohistochemistry Based Companion Diagnostic Kit-MTX3-Product Status 12

Immunohistochemistry Based Companion Diagnostic Kit-MTX3-Product Description 12

Immunohistochemistry Based Companion Diagnostic Kit-MTX5-Product Status 13

Immunohistochemistry Based Companion Diagnostic Kit-MTX5-Product Description 13

Oncomatryx Biopharma SL, Key Employees 15

Glossary 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Oncomatryx Biopharma SL, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Spanish Breast Cancer Research Group

Multidisplinary Group on Digestive Cancer

Curaxys SL

Dynamic Solutions